UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000016954 |
|---|---|
| Receipt number | R000019678 |
| Scientific Title | A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of S-588410 as adjuvant therapy after curative resection in patients with esophageal cancer |
| Date of disclosure of the study information | 2015/04/01 |
| Last modified on | 2023/11/08 14:38:45 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/03/27 21:51:29 | ||
| 2 | Update | 2017/09/27 10:21:09 | Division name Division name Name of primary person or sponsor Organization |
|
| 3 | Update | 2018/03/29 13:57:03 | Last name of lead principal investigator Last name of lead principal investigator Last name of contact person Last name of contact person |
|
| 4 | Update | 2018/03/29 13:57:46 | Recruitment status |
|
| 5 | Update | 2018/10/01 07:44:42 | Last name of contact person Name of person sending information Name of person sending information |
|
| 6 | Update | 2020/09/30 17:01:45 | Date of IRB Anticipated trial start date Last follow-up date |
|
| 7 | Update | 2021/09/30 12:08:55 | Recruitment status |
|
| 8 | Update | 2023/10/31 18:26:28 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Name of person sending information Name of person sending information Division name Address Address TEL Organization Organization Organization Division Category of Funding Organization Organization Organization Address Address Tel |
|
| 9 | Update | 2023/11/08 14:16:38 | Nationality of Funding Organization Nationality of Funding Organization |
|
| 10 | Update | 2023/11/08 14:38:45 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures Plan to share IPD Plan to share IPD |
